High frequency of PfK13mutations confering artesunate-resistance in Uganda: effect on clinical outcomes in severe malaria
Starting on:
Oct 2, 2025
Ending on:
Oct 2, 2025
Moderator(s):
Venue:
KWTRP Kilifi campus
Max Credits:
3 Points

Provider:
KEMRI-WELLCOME TRUST RESEARCH PROGRAMME
Claim Points

High frequency of PfK13mutations confering artesunate-resistance in Uganda: effect on clinical outcomes in severe malaria

Starting on:
Oct 2, 2025
Ending on:
Oct 2, 2025
Venue:
KWTRP Kilifi campus

Description

Regular scientific seminar

Objectives

High frequency of PfK13mutations confering artesunate-resistance in Uganda: effect on clinical outcomes in severe malaria

Presenters

  1. Prof. Kath Maitland
    Kathryn Maitland is a British paediatrician who is professor of infectious diseases at Imperial College London, director of the ICCARE Centre at the Institute of Global Health Innovation and an Honorary Fellow at Medical Research Council Clinical Trials Unit, University College, London. Since 2000 she has been based at the KEMRI-Wellcome Trust Research Programme, in Kilifi, Kenya.
    KWTRP, Imperial College, London

Search For CPD Activity